Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Cross-sectional, Longitudinal, Multi-center, Diagnostic Study to Evaluate the Influence of Acromegaly on Glucose Tolerance and to Evaluate the Changes of Impaired Glucose Tolerance During Standard Treatment of Acromegaly.

NCT00663000 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT00663000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00663000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Cross-sectional, Longitudinal, Multi-center, Diagnostic Study to Evaluate the Influence of Acromegaly on Glucose Tolerance and to Evaluate the Changes of Impaired Glucose Tolerance During Standard Treatment of Acromegaly.
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Completed
Start date
April 30, 2008
Completion date
December 31, 2012
Enrollment
138 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly, diabetes, impaired glucose tolerance, insulin resistance